The NDA includes a combination of Blenrep with bortezomib plus dexamethasone (BorDex) or pomalidomide plus dexamethasone ...

Japan's Ministry of Health, Labour and Welfare (MHLW) has approved for GSK’s Nucala (mepolizumab) for the treatment of adults ...

King of Prussia, Pennsylvania Monday, September 16, 2024, 17:00 Hrs [IST] ...

Rhythm Technologies announced that it received approval in Japan for its Zio long-term continuous monitoring (LTCM) system.

Japan’s MHLW accepts for review GSK’s NDA for Blenrep combinations in relapsed/refractory multiple myeloma: London, UK Wednesday, September 18, 2024, 10:00 Hrs [IST] GSK plc a ...

Osaka Metropolitan University researchers analyzed the incidence in Japan of COVID-19-associated pulmonary aspergillosis ...

Investigating Japanese longevity reveals the impact of lifestyle medicine and government strategies on health, offering ...

(RTTNews) - iRhythm Technologies, Inc. (IRTC), a digital health care company, Wednesday said it has received approval from the Japanese ...

Largest Hospitals in Japan by Bed Size 2021 Japan provides universal health coverage, with its statutory health insurance ...

Drug maker GSK plc (GSK, GSK.L) announced Tuesday that Blenrep (belantamab mafodotin) combinations in relapsed/refractory multiple ...